Acetazolamide in Acute Decompensated Heart Failure with Volume Overload

One of the most important news items during this year's European Society of Cardiology meeting was unrelated to a new drug or technology. The ADVOR trial demonstrated that IV acetazolamide significantly improved decongestion in patients with acute on chronic decompensated heart failure. We welcome Dr. Wilfried Mullens, the principal investigator of this trial, to discuss the rationale for the trial and explain its results.
Acetazolamide in Acute Decompensated
Heart Failure with Volume Overload:
acrobat.adobe....
Follow the Yale Heart Failure Program:
/ yalehf

[@sleepygrumpy]

Excellent discussion, I had not heard about ADVOR until today